To investigate the long-term effects of transient blockade of IFNAR1, we administered the IFNAR1-specific antibody on day −1, 0, and 1 after infection as performed previously and monitored the course of chronic viral infection for 30 days. This evidence concerns the gene IFNAR1 and viral infectious disease.